Skip to main content

Published locations for Mosaic HIV-1 vaccine stimulates broad antigenicity, enters phase 2b human efficacy trial

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Mosaic HIV-1 vaccine stimulates broad antigenicity, enters phase 2b human efficacy trial

User login

  • Reset your password
  • /content/mosaic-hiv-1-vaccine-stimulates-broad-antigenicity-enters-phase-2b-human-efficacy-trial
  • /idpractitioner/article/170201/hiv/mosaic-hiv-1-vaccine-stimulates-broad-antigenicity-enters-phase-2b
  • /internalmedicinenews/article/170201/hiv/mosaic-hiv-1-vaccine-stimulates-broad-antigenicity-enters
  • /infectiousdisease/article/170201/hiv/mosaic-hiv-1-vaccine-stimulates-broad-antigenicity-enters-phase
  • /internalmedicine/article/170201/hiv/mosaic-hiv-1-vaccine-stimulates-broad-antigenicity-enters-phase